GEM-CLARIDEX: Lenalidomide and Dexamethasone (Ld) Versus Clarithromycin / Lenalidomide [Revlimid] / Dexamethasone (BiRd) as Initial Therapy in Multiple Myeloma
Phase of Trial: Phase III
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Lenalidomide (Primary) ; Clarithromycin; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 28 Nov 2017 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 28 Nov 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Dec 2017.
- 17 Oct 2015 New trial record